On Thursday, the Shanghai Composite Index opened low and went high, the momentum was like a rainbow, the bull was angry, the highest was 2961 points, the lowest was 2909 points, the amount of energy could cross the pressure line and effectively release, ** closed in the medium and long white line, and the bulls were obviously dominant. We believe that this New Year's Eve has begun, and the over-falling will continue, so investors are requested to pay more attention to it. Below 3000 points has a certain investment value, and it is expected to rebound to the 3050-3100 point area.
On the 60-minute chart, the short-term resistance is in the range of 2980-3000 points, the lower support is in the range of 2930-2950 points, and the 2950 points can only be attacked near 3000 points after effectively gaining a firm foothold, and returning to above 3000 points is just around the corner. It is expected that after a small retracement in the market on Friday, the bulls will continue to fight back, focusing on whether the volume can continue to be released. The 2024 market** will officially start after the holiday, and the first quarter will be a rare and excellent trading opportunity.
The STAR 50 and the GEM index both closed at the large white line, and the collective attack of the bulls is more obvious, and it is expected to have a certain degree of sustainability in the short term. It is expected that the Shanghai Composite Index will fluctuate in the range of 2950-3000 points on Friday.
Jinyu Medical: It is planned to repurchase shares for 50 million yuan to 100 million yuan.
Ruifeng Bank: The implementation of stock price stabilization measures has been completed.
Kanghui Pharmaceutical: It is planned to invest in the establishment of Shaanxi Qinyao generic technology research***
Soochow** completed the issuance of 2 billion yuan of short-term financing bonds.
Helin Micro-Nano: It is planned to increase the implementation subject and implementation location of the fund-raising project.
The content of the article belongs to the collation and statistics of public information, and does not constitute a recommendation or any basis for buying and selling.